Document Detail

Gut response. Therapy with ingested immunomodulatory proteins.
MedLine Citation:
PMID:  9341578     Owner:  NLM     Status:  MEDLINE    
The recent negative results of the 2-year phase III trial of enteral myelin (Myloral), a preparation of bovine myelin given orally in multiple sclerosis (MS), warn that the efficacy of oral tolerization (ie, inducing hyporesponsiveness to a specific autoantigen) and the attractiveness of oral desensitization in animal models of MS may not translate into clinical practice. However, such failure should not deter further examination of the mouth, an immunologically interesting and patient-friendly route for immunomodulatory proteins.
S A Brod
Related Documents :
9875708 - The wheat proteins puroindoline-a and alpha1-purothionin induce nodal swelling in myeli...
12480078 - Specificity of autoantibodies to epitopes of myelin proteins in multiple sclerosis.
16856138 - Experimental autoimmune encephalomyelitis induction in peptidylarginine deiminase 2 kno...
3237338 - Lipid composition of myelin and protein--lipid complex in a neurological rabbit mutant.
7900868 - Anp increases capillary permeability to protein independent of perfusate protein compos...
20481348 - Reducing nitrogen excretion and soybean meal use by feeding a lower rumen degradable pr...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Archives of neurology     Volume:  54     ISSN:  0003-9942     ISO Abbreviation:  Arch. Neurol.     Publication Date:  1997 Oct 
Date Detail:
Created Date:  1997-11-19     Completed Date:  1997-11-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0372436     Medline TA:  Arch Neurol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1300-2     Citation Subset:  AIM; IM    
Department of Neurology, University of Texas Health Science Center at Houston, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adjuvants, Immunologic / administration & dosage*,  therapeutic use
Administration, Oral
Clinical Trials as Topic
Multiple Sclerosis / therapy*
Myelin Sheath / chemistry*
Nerve Tissue Proteins / administration & dosage*,  therapeutic use
Treatment Failure
Grant Support
Reg. No./Substance:
0/Adjuvants, Immunologic; 0/Nerve Tissue Proteins

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Bilateral temporal lobe volume reduction parallels cognitive impairment in progressive aphasia.
Next Document:  Changes in emergency department turnaround time performance from 1990 to 1993. A comparison of two C...